Current status and perspectives in the surgical and oncological management of intrahepatic cholangiocarcinoma

被引:2
|
作者
Dhote, Alix [1 ,2 ]
Tzedakis, Stylianos [1 ,3 ]
Shapira, Ortal Itzaki [1 ]
Nassar, Alexandra [1 ,3 ]
Boudjema, Karim [4 ]
Fuks, David [1 ,3 ,5 ]
机构
[1] Cochin Port Royal Hosp Grp, AP HP, Digest Hepatobiliary & Endocrine Surg Dept, DMU Cancerol & Med Surg Specialties, Paris, France
[2] Paris Sorbonne Univ, Paris, France
[3] Paris Cite Univ, Paris, France
[4] Rennes 1 Univ, Pontchaillou Hosp, Hepatobiliary & Digest Surg Dept, Rennes, France
[5] Univ Paris Cite, Hop Cochin, Serv Chirurg Digest Hepatobiliaire & Endocrinienne, Paris, France
关键词
Intrahepatic cholangiocarcinoma; Hepatectomy; Chemotherapy; Radio-embolization; neoadjuvant treatment; immunotherapy; PORTAL-VEIN EMBOLIZATION; LAPAROSCOPIC LIVER RESECTION; OPEN-LABEL; RADIATION-THERAPY; CHEMOTHERAPY; MULTICENTER; GEMCITABINE; TRANSPLANTATION; REGENERATION; CISPLATIN;
D O I
10.1016/j.jviscsurg.2023.07.007
中图分类号
R61 [外科手术学];
学科分类号
摘要
=Intrahepatic cholangiocarcinoma (ICC) is the second most common primary liver tumor after hepatocellular carcinoma (HCC). Management depends on their resectability at the time of diagnosis. Two types can be distinguished by imaging: resectable ICCs amenable to surgery and locally advanced and/or metastatic ICCs, that are treated by chemotherapy, radiotherapy or loco-regional treatment (radioembolization, chemoembolization, intra-arterial chemotherapy and thermoablation). Over the last decade, the management strategy for these tumors has been modified by the appearance of loco-regional treatments as well as the introduction of immunotherapy that have shown their efficacy in the control of ICC. The aim of this review is to describe the current status of treatments for ICCs, as well as the different therapeutic strategies being assessed.(c) 2023 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:346 / 355
页数:10
相关论文
共 50 条
  • [21] Radiofrequency Ablation in the Management of Unresectable Intrahepatic Cholangiocarcinoma
    Fu, Ying
    Yang, Wei
    Wu, Wei
    Yan, Kun
    Xing, Bao Cai
    Chen, Min Hua
    JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2012, 23 (05) : 642 - 649
  • [22] Advances in the treatment of intrahepatic cholangiocarcinoma: An overview of the current and future therapeutic landscape for clinicians
    Moris, Dimitrios
    Palta, Manisha
    Kim, Charles
    Allen, Peter J.
    Morse, Michael A.
    Lidsky, Michael E.
    CA-A CANCER JOURNAL FOR CLINICIANS, 2023, 73 (02) : 198 - 222
  • [23] Cholangiocarcinoma: a site-specific update on the current state of surgical management and multi-modality therapy
    Turgeon, Michael K.
    Maithel, Shishir K.
    CHINESE CLINICAL ONCOLOGY, 2020, 9 (01)
  • [24] Current Status on Cholangiocarcinoma and Gallbladder Cancer
    Ebata, Tomoki
    Ercolani, Giorgio
    Alvaro, Domenico
    Ribero, Dario
    Di Tommaso, Luca
    Valle, Juan W.
    LIVER CANCER, 2017, 6 (01) : 59 - 65
  • [25] Surgical Aspects of Intrahepatic Cholangiocarcinoma
    Kupietzky, Amram
    Ariche, Arie
    CANCERS, 2022, 14 (24)
  • [26] Current status of liver transplantation for cholangiocarcinoma
    Twohig, Patrick
    Peeraphatdit, Thoetchai Bee
    Mukherjee, Sandeep
    WORLD JOURNAL OF GASTROINTESTINAL SURGERY, 2022, 14 (01): : 1 - 11
  • [27] Intrahepatic cholangiocarcinoma: Epidemiology, risk factors, diagnosis and surgical management
    Zhang, Han
    Yang, Tian
    Wu, Mengchao
    Shen, Feng
    CANCER LETTERS, 2016, 379 (02) : 198 - 205
  • [28] Analysis of Oncological Outcomes After Robotic Liver Resection for Intrahepatic Cholangiocarcinoma
    Shapera, Emanuel A.
    Ross, Sharona
    Syblis, Cameron
    Crespo, Kaitlyn
    Rosemurgy, Alexander
    Sucandy, Iswanto
    AMERICAN SURGEON, 2023, 89 (06) : 2399 - 2412
  • [29] Intrahepatic cholangiocarcinoma: current management and emerging therapies
    Rahnemai-Azar, Amir A.
    Weisbrod, Allison B.
    Dillhoff, Mary
    Schmidt, Carl
    Pawlik, Timothy M.
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2017, 11 (05) : 439 - 449
  • [30] Current management and prognosis of intrahepatic cholangiocarcinoma in France
    Borie, F.
    Niampa, H.
    Bouvier, A. -M.
    Faivre, J.
    Launoy, G.
    Delafosse, P.
    Velten, M.
    Buemi, A.
    Peng, J.
    Grosclaude, P.
    Tretarre, B.
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2009, 33 (10-11): : 971 - 976